Investment Rating - The report maintains a rating of "Outperform" for the company [2] Core Views - The company reported its Q3 2024 results, which met expectations, with a revenue of 22.05 billion yuan for the first three quarters, showing a year-on-year stability, and a net profit of 1.314 billion yuan, reflecting a 38% increase year-on-year [2] - The Q3 2024 revenue was 8.646 billion yuan, representing a 4% year-on-year increase and a 33% quarter-on-quarter increase, with a net profit of 509 million yuan, up 53% year-on-year and 20% quarter-on-quarter [2] - The report highlights the high prosperity in the phosphate chemical sector, with improved performance in fertilizers and organic silicon, while also noting a decline in fertilizer sales volume [2] - The company is expected to benefit from the rebound in glyphosate and organic silicon prices, with potential contributions to Q4 performance [2] - The special chemicals segment remains stable, with ongoing efforts in transformation and upgrading [2] Summary by Sections Financial Performance - For Q3 2024, the company achieved a gross margin of 18.86%, a year-on-year increase of 6.25 percentage points, and a net profit margin of 6.01%, up 1.83 percentage points year-on-year [2] - The company’s revenue for 2024 is projected to be 29.117 billion yuan, with a net profit of 1.850 billion yuan, and an EPS of 1.68 yuan [3][8] Market Data - As of October 25, 2024, the closing price was 23.20 yuan, with a market capitalization of 25.596 billion yuan [4] - The company has a price-to-earnings ratio of 14 times for the 2024 earnings forecast [3][4] Strategic Outlook - The company aims to strengthen its phosphate, silicon, and sulfur-based materials, as well as new materials in microelectronics, with a gradual increase in profit contribution from these segments [2] - The report emphasizes the company's leading position in the industry and its commitment to ongoing product and process development [2]

Investment Rating - The report maintains a "Strong Buy" rating for the company, with a target price of 32.10 CNY [1]. Core Insights - The company reported a revenue of 22.05 billion CNY for the first three quarters of 2024, a slight increase of 0.04% year-on-year. The net profit attributable to shareholders reached 1.314 billion CNY, up 37.85% year-on-year, while the net profit excluding non-recurring items was 1.269 billion CNY, an increase of 44.35% year-on-year [1]. - In Q3 2024, the company achieved a revenue of 8.646 billion CNY, representing a year-on-year increase of 3.54% and a quarter-on-quarter increase of 32.69%. The net profit attributable to shareholders for Q3 was 509 million CNY, up 52.73% year-on-year and 20.26% quarter-on-quarter [1]. - The report highlights a significant recovery in demand for the company's main products, with the agricultural chemicals, fertilizers, specialty chemicals, and organic silicon segments showing varying performance in terms of sales volume and price adjustments [1]. Financial Performance Summary - For the first three quarters of 2024, the company generated revenues from its segments as follows: agricultural chemicals (4.003 billion CNY), fertilizers (3.000 billion CNY), specialty chemicals (3.971 billion CNY), and organic silicon (1.858 billion CNY) [1]. - The gross margin for the first three quarters was 17.96%, with a net profit margin of 6.02%. In Q3, the gross margin was 18.86%, and the net profit margin was 6.01%, indicating a year-on-year improvement in profitability [1]. - The report notes that the company is transitioning towards new chemical materials, with its subsidiary, Xingfu Electronics, receiving approval for an IPO, which is expected to enhance the company's growth prospects [1]. Financial Forecasts - The company’s projected revenues for 2024 to 2026 are 29.207 billion CNY, 31.834 billion CNY, and 32.219 billion CNY, respectively, with corresponding net profits of 1.841 billion CNY, 2.360 billion CNY, and 2.576 billion CNY [2]. - The report adjusts the net profit forecasts for 2024-2026 to 1.841 billion CNY, 2.360 billion CNY, and 2.576 billion CNY, reflecting a price-to-earnings ratio of 13.9x, 10.8x, and 9.9x for the respective years [1][2].

Investment Rating - The investment rating for the company is "Outperform the Market" [3][10][11] Core Views - The company reported a significant year-on-year increase in net profit of 52.73% in the third quarter, driven by stable operations in the phosphate chemical industry [4][10] - The company is expected to maintain high phosphate rock prices due to declining grades and increasing downstream demand, with a forecast for continued high prices in Q4 2024 [7][10] - The IPO application for the subsidiary Xingfu Electronics has been approved, indicating strong growth potential in the electronic chemicals sector [9][10] Summary by Sections Financial Performance - In the first three quarters of 2024, the company achieved revenue of 22.05 billion yuan, a slight increase of 0.04% year-on-year, and a net profit of 1.314 billion yuan, up 37.85% year-on-year [4][10] - The third quarter alone saw revenue of 8.646 billion yuan, a 3.54% increase year-on-year, and a net profit of 509 million yuan, reflecting a 52.73% year-on-year growth and a 20.26% quarter-on-quarter increase [4][10] Business Overview and Outlook - The main profit sources for the company include phosphate rock, phosphate fertilizer, and certain specialty chemicals, while glyphosate and organosilicon segments remain under pressure [4][10] - The company has multiple projects underway, including a 20,000 tons/year 2,4-D project and a 400,000 tons/year organosilicon new materials project, which are expected to enhance its competitive edge in green pesticides and silicon-based materials [10][11] Valuation and Earnings Forecast - The company maintains its earnings forecast for 2024-2026, projecting net profits of 1.857 billion yuan, 2.160 billion yuan, and 2.446 billion yuan respectively, with growth rates of 34.7%, 16.3%, and 13.2% [10][11] - The diluted EPS is expected to be 1.67 yuan, 1.94 yuan, and 2.20 yuan for the years 2024, 2025, and 2026, respectively, with corresponding PE ratios of 13.9, 11.9, and 10.5 [10][11]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][9][27] Core Views - The company has shown significant growth in its Q3 2024 performance, with a notable increase in net profit and sales revenue, driven by high phosphate prices and strong product demand [2][3][9] - The company is actively advancing its key projects, particularly in new materials, which are expected to contribute to future profit growth [4][5][9] Summary by Relevant Sections Market Performance - For Q3 2024, the company achieved revenue of 86.46 billion yuan, a year-on-year increase of 3.54% and a quarter-on-quarter increase of 32.69% [2] - The net profit attributable to shareholders for Q3 2024 was 5.09 billion yuan, reflecting a year-on-year increase of 52.73% and a quarter-on-quarter increase of 20.26% [2] Financial Metrics - The company reported a gross profit margin of 18.86% for Q3 2024, up 6.25 percentage points year-on-year [2] - The return on equity (ROE) for Q3 2024 was 2.43%, an increase of 0.81 percentage points year-on-year [2] Product Performance - The sales volume of glyphosate reached 62,500 tons in Q3 2024, a year-on-year increase of 54.70% [2] - The average price of phosphate rock in Q3 2024 was 1,009 yuan/ton, a year-on-year increase of 20.51% [2][3] Future Outlook - The company forecasts revenues of 296 billion yuan, 324 billion yuan, and 343 billion yuan for 2024, 2025, and 2026 respectively, with net profits of 18.17 billion yuan, 22.23 billion yuan, and 26.51 billion yuan [9][27] - The company is expected to maintain a strong position in the phosphate industry due to its resource advantages and ongoing development in new materials [5][9]

Investment Rating - The report maintains a "Buy" rating for the company [2][3]. Core Views - The company's performance in Q3 slightly exceeded expectations, driven by stable phosphate ore prices and a recovery in glyphosate prices, along with strong performance in the specialty chemicals segment [2]. - The report forecasts that the phosphate chemical industry will remain strong, and the silicon chemical sector is expected to recover in Q4 [2]. - The earnings per share (EPS) estimates for 2024-2026 are projected to be 1.63, 2.01, and 2.25 yuan respectively, with a target price maintained at 24.34 yuan [2]. Financial Performance Summary - In Q3 2024, the company achieved a revenue of 22.05 billion yuan, a year-on-year increase of 0.04%. The net profit attributable to shareholders was 1.314 billion yuan, up 37.85% year-on-year [2]. - For Q3 alone, revenue was 8.646 billion yuan, reflecting a 3.54% year-on-year growth, while net profit was 509 million yuan, marking a 52.73% year-on-year increase and a 20.26% quarter-on-quarter increase [2]. - The gross margin for Q3 was 18.86%, significantly up by 6.25 percentage points year-on-year, although it slightly decreased by 1.62 percentage points quarter-on-quarter [2]. Market Outlook - The phosphate fertilizer market is expected to enter a winter storage demand peak in Q4, while phosphate ore supply is anticipated to decrease as it enters a rest period [2]. - Glyphosate prices are expected to rise due to declining inventory levels in domestic factories since August, with a potential recovery in North American purchasing in Q4 [2]. - The silicon industry is projected to see a reduction in supply during the traditional dry season, with improving fundamentals in the photovoltaic sector likely to boost sentiment in the silicon supply chain [2].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has shown continued improvement in Q3 performance, with stable demand in specialty chemicals and fertilizers, and a significant increase in net profit [3][4] - The listing of the subsidiary, Xingfu Electronics, is expected to contribute to new profit growth [4] - The company is on track to transition into a world-class fine chemical enterprise, supported by ongoing improvements in its industrial chain [3] Financial Performance Summary - For Q3 2024, the company achieved revenue of 86.46 billion yuan, a year-on-year increase of 3.54% and a quarter-on-quarter increase of 32.69% [3] - The net profit attributable to shareholders for Q3 2024 was 5.09 billion yuan, reflecting a year-on-year increase of 52.73% and a quarter-on-quarter increase of 20.26% [3] - The company’s revenue for the first three quarters of 2024 was 220.50 billion yuan, with a year-on-year growth of 0.04% [3] Product Performance - In the first three quarters of 2024, the sales amounts for specialty chemicals, pesticides, fertilizers, and organic silicon series were 39.7 billion yuan, 40.0 billion yuan, 30.0 billion yuan, and 18.6 billion yuan respectively [4] - The average selling prices for these products showed a decline in specialty chemicals and pesticides, while fertilizers experienced a price increase [5] Profitability Metrics - The company’s gross margin and net margin for the first three quarters of 2024 were 17.96% and 6.02%, respectively [4] - The projected net profits for 2024-2026 are 17.15 billion yuan, 21.95 billion yuan, and 26.54 billion yuan, with corresponding EPS of 1.55 yuan, 1.99 yuan, and 2.41 yuan [3][4] Valuation Metrics - The current stock price corresponds to a PE ratio of 14.9 for 2024, 11.7 for 2025, and 9.6 for 2026 [3][4] - The company’s market capitalization is approximately 255.96 billion yuan [1]

证券代码：600141 证券简称：兴发集团 公告编号：临 2024-063 转债代码：110089 转债简称：兴发转债 湖北兴发化工集团股份有限公司 十一届五次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 湖北兴发化工集团股份有限公司(以下简称"公司")于 2024 年 10 月 25 日以电子通讯方式召开了第十一届董事会第五次会议。会议通知于 2024 年 10 月 20 日以电子通讯方式发出。会议应收到表决票 13 张，实际收到表决票 13 张，符合《公司法》及《公司章程》的有关规定。经与会董事认真审议，形成 如下决议公告： 一、审议通过了关于2024 年第三季度报告的议案 第三季度报告全文见上海证券交易所网站www.sse.com.cn。 表决结果：13 票同意，0 票反对，0 票弃权。 二、审议通过了关于聘任 2024 年度审计机构的议案 详细内容见关于变更会计师事务所的公告，公告编号：临 2024-065。 表决结果：13 票同意，0 票反对，0 票弃权。 本议案尚需提交股东会审议。 三、审议 ...

Financial Performance - The company's operating revenue for Q3 2024 reached CNY 8,646,031,816.82, an increase of 3.54% compared to the same period last year[2]. - Net profit attributable to shareholders was CNY 509,257,850.56, reflecting a significant increase of 52.73% year-on-year[2]. - The net profit after deducting non-recurring gains and losses was CNY 514,294,577.40, up 55.81% from the previous year[3]. - Basic earnings per share for the current period was CNY 0.46, representing a growth of 31.43% compared to the same period last year[3]. - Total operating revenue for the first three quarters of 2024 reached ¥22,049,996,154.75, slightly up from ¥22,041,097,765.13 in the same period of 2023[17]. - Net profit for the first three quarters of 2024 was ¥1,327,406,604.25, compared to ¥998,269,640.16 in the previous year, indicating a growth of approximately 32.9%[18]. - The total comprehensive income for the third quarter of 2024 reached CNY 1,309,819,790.17, compared to CNY 993,027,404.98 in the same period of 2023, representing an increase of approximately 31.8%[19]. - Basic earnings per share increased to CNY 1.19 from CNY 0.91, reflecting a growth of 30.8% year-over-year[19]. Assets and Liabilities - The total assets of the company at the end of the reporting period amounted to CNY 47,119,080,114.60, an increase of 5.15% from the end of the previous year[3]. - The company's total assets increased to CNY 47.12 billion as of September 30, 2024, compared to CNY 44.81 billion at the end of 2023, reflecting a growth of approximately 5.8%[13]. - The total liabilities as of the end of Q3 2024 amounted to ¥24,535,138,064.88, up from ¥22,687,131,167.07 in the previous year[16]. - The equity attributable to shareholders increased to ¥21,233,578,867.85 from ¥20,858,799,718.30, showing a positive trend in shareholder value[16]. Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 774,057,424.17, showing a decrease of 9.07% compared to the same period last year[3]. - Net cash flow from operating activities for the first three quarters of 2024 was CNY 774,057,424.17, down from CNY 851,299,950.62 in the same period of 2023, a decrease of about 9.1%[21]. - Cash inflow from operating activities totaled CNY 13,882,830,567.61, while cash outflow was CNY 13,108,773,143.44, resulting in a net cash flow of CNY 774,057,424.17[21]. - Investment activities generated a net cash outflow of CNY 1,026,330,203.42, compared to a net outflow of CNY 2,001,348,403.05 in the previous year, indicating a reduction in cash outflow by approximately 48.7%[21]. - Cash and cash equivalents at the end of the period were CNY 1,603,886,518.41, down from CNY 2,488,490,971.32 at the end of the same period last year, a decrease of about 35.5%[22]. - Total cash inflow from financing activities was CNY 4,854,309,831.00, down from CNY 5,499,700,762.71, reflecting a decrease of about 11.7%[22]. - The net cash flow from financing activities was negative at CNY -199,551,138.13, an improvement from CNY -1,042,165,258.45 in the previous year[22]. Investments and Acquisitions - The company completed the acquisition of 100% equity in Gu Cheng Xing Fa New Materials Co., Ltd. for CNY 328.96 million, enhancing its market position[4]. - Research and development expenses increased to ¥838,845,311.56 from ¥757,793,996.50, highlighting the company's commitment to innovation[17]. - The company is actively transitioning towards new chemical materials, with a focus on research and development of specialty chemicals, which has positively impacted its performance[12]. - The company has maintained a strong development trend and profitability in its specialty chemicals segment, contributing significantly to overall performance[12]. - The company continues to strengthen its product and process R&D efforts, which are crucial for its strategic transformation and market expansion[12]. Shareholder Information - The company reported a total of 72,479 common shareholders at the end of the reporting period[9]. - The company has no significant changes in the shareholding structure or financing activities among the top shareholders during the reporting period[11]. Other Financial Metrics - The weighted average return on equity increased to 2.41%, up 0.48 percentage points from the previous year[3]. - Non-recurring gains and losses for the current period totaled CNY -5,036,726.84, influenced by various factors including asset disposal losses[5]. - The company reported a significant increase in other income, which rose to ¥118,541,875.54 from ¥43,827,359.54 year-over-year[18]. - The financial expenses for the first three quarters of 2024 were ¥274,510,887.61, compared to ¥231,546,165.27 in the same period of 2023, indicating higher financing costs[17]. - The company's contract liabilities increased to ¥867,976,091.82 from ¥852,845,561.54, reflecting growth in customer prepayments[16].

湖北兴发化工集团股份有限公司 十一届五次监事会决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 湖北兴发化工集团股份有限公司(以下简称"公司")于 2024 年 10 月 25 日以电子通讯方式召开了第十一届监事会第五次会议。会议通知于 2024 年 10 月 20 日以电子通讯方式发出。会议应收到表决票 5 张，实际收到表决票 5 张， 符合《公司法》及《公司章程》的有关规定。经与会监事认真审议公司《关于 2024 年第三季度报告的议案》，形成如下决议公告： 证券代码：600141 证券简称：兴发集团 公告编号：临 2024-064 转债代码：110089 转债简称：兴发转债 3.公司监事会成员保证公司 2024 年第三季度报告所披露的信息真实、准 确、完整地反映了公司前三季度的经营情况和财务状况，不存在虚假记载、误 导性陈述和重大遗漏，并对其内容的真实性、准确性和完整性承担个别连带责 任。 第三季度报告全文见上海证券交易所网站www.sse.com.cn。 表决结果：5 票同意，0 票反对，0 票弃权。 特此 ...

| 主要产品 | 2024 年1 | 至9 月平均售价 （元/吨） | 2023年1至9月平均售价 （元/吨） | 变动比率（%） | | --- | --- | --- | --- | --- | | 特种化学品 | | 10,375.23 | 11,319.01 | -8.34 | | 农药 | | 21,381.74 | 25,710.35 | -16.84 | | 肥料 | | 3,116.07 | 2,937.82 | 6.07 | | 有机硅系列产品 | | 10,705.07 | 11,819.17 | -9.43 | 一、主要产品的产量、销量及收入实现情况（不含税） 主要产品 2024 年1 至9 月产量 （万吨） 2024年1至9月销量 （万吨） 2024 年1 至9 月销售金额 （万元） 特种化学品 44.33 38.27 397,061.52 农药 19.61 18.72 400,344.25 肥料 104.92 96.24 299,879.78 有机硅系列产品 18.58 17.36 185,843.16 | 主要原料 | 2024 年1 至9 月平均进价 | 2023年1至9月平均进 ...